Zachariah Bobby

Zachariah Bobby

Auto-generated profile, based on publicly available information

Zachariah Bobby

Department of Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Experimental Gerontology
Verified
Journal Article
Closed access
PSP. Sankar
P. Sankar
BZBobby Zachariah
Bobby Zachariah
VVV. Vickneshwaran
V. Vickneshwaran
SJSajini Elizabeth Jacob
Sajini Elizabeth Jacob
MSM.G. Sridhar
M.G. Sridhar

1 January 2021 in Placenta
Verified
Journal Article
Closed access
MBManoharan Balachandiran
Manoharan Balachandiran
ZBZachariah Bobby
Zachariah Bobby
GDGowri Dorairajan
Gowri Dorairajan
VGVictorraj Gladwin
Victorraj Gladwin
VVVickneshwaran Vinayagam
Vickneshwaran Vinayagam
RPRajaa Muthu Packirisamy
Rajaa Muthu Packirisamy

1 June 2008 in Clinical and Experimental Medicine
Verified
Journal Article
Closed access
PDF file
NNNanda Nivedita
Nanda Nivedita
ZBZachariah Bobby
Zachariah Bobby
AHAbdoul Hamide
Abdoul Hamide

16 February 2020 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
NGNila Shaji Geetha
Nila Shaji Geetha
ZBZachariah Bobby
Zachariah Bobby
GDGowri Dorairajan
Gowri Dorairajan
SJSajini E. Jacob
Sajini E. Jacob
Background: Pregnancy is a metabolic state which demands increased iron bioavailability. While in preeclampsia, due to the placental vascular events there is an iron surplus environment along with inflammation and placental hypoxia. Routinely in India iron is supplemented to all pregnant women irrespective of their general physical condition. Hepcidin a regulator of iron metabolism protects the cells from iron mediated cytotoxicity. Objective: To find out whether hepcidin gets induced as a protective mechanism in preeclampsia patients in order to combat the environment of iron overload, oxidative stress, and endothelial dysfunction. Methods: A cross-sectional study with follow up was carried out in a South Indian Tamil population. Forty healthy pregnant women and forty preeclampsia patients in the gestational age 32 ± 4 weeks were recruited (n = 80). Biochemical analysis to assess the serum levels of the following were carried out (1) indices of iron homeostasis – serum iron, ferritin, transferrin, hepcidin, (2) endothelial dysfunction –serum assymetric dimethyl arginine (ADMA) (3) oxidative stress – Malon di aldehyde (MDA) and ferric reducing ability of plasma (FRAP). Kolmogorov-Smirnov test, Mann-Whitney U test, Spearman’s correlation, linear regression and ROCAUC analysis were performed to understand their relationship with each other. Results: Levels of serum iron, ferritin, transferrin saturation, hepcidin, and MDA/FRAP ratio were elevated significantly in preeclampsia patients compared to controls, while serum transferrin levels were significantly decreased in them. Hepcidin levels showed a significant positive correlation with serum ADMA, and MDA/FRAP. Serum hepcidin, transferrin saturationand MDA/FRAP ratio is useful in differentiating pre-eclampsia patients from healthy pregnant women. Conclusion: Iron supplementation in preeclampsia patients might have led to a state of iron overload, which might have caused oxidative stress and endothelial dysfunction in preeclampsia patients. The rise in hepcidin levels in this scenario may be viewed as a protective mechanism to combat the iron overload mediated cytotoxicity.

22 January 2020 in Experimental and Clinical Endocrinology & Diabetes
Verified
Journal Article
Closed access
PDF file
MBManoharan Balachandiran
Manoharan Balachandiran
ZBZachariah Bobby
Zachariah Bobby
GDGowri Dorairajan
Gowri Dorairajan
SJSajini Elizabeth Jacob
Sajini Elizabeth Jacob
VGVictorraj Gladwin
Victorraj Gladwin
RPRajaa Muthu Packirisamy
Rajaa Muthu Packirisamy
Introduction Gestational diabetes mellitus (GDM) exhibit altered placental lipid metabolism. The molecular basis of this altered metabolism is not clear. Altered placental expression of proteins of lipogenesis and fatty acid oxidation may be involved in the placental accumulation of triacylglycerols (TG). The present study was aimed at investigating the differential expressions of placental proteins related to lipid metabolism among GDM women in comparison with control pregnant women (CPW) and to correlate them with maternal and fetal lipid parameters as well as altered fetal growth.Materials and Methods Maternal blood, cord blood, and placental samples were collected from GDM and CPW. The biochemical parameters, glucose, lipid profile and free fatty acids (FFA) were measured. The placental TG content was measured. Differential placental expressions of proteins; phosphatidylinositol-3-kinase (PI3K) p85α, PI3K p110α,liver X receptor alpha (LXRα), sterol regulatory element binding protein1(SREBP1), fatty acid synthase (FAS), stearyl CoA desaturase1 (SCD1), lipoprotein lipase (LPL),Peroxisome proliferator-activated receptor (PPAR)α and PPARγ were analysed by western blotting and immunohistochemistry.Results Placental protein expressions of PI3K p110α, LXRα, FAS, SCD1, and LPL were found to be significantly higher, whereas PPARα and PPARγ were lower in GDM women compared with CPW. The placental TG content and cord plasma FFA were increased in GDM women compared with CPW. The placental TG content positively correlated with Ponderal index of GDM new-borns.Conclusion Differential expressions of placental proteins related to lipid metabolism in GDM might have led to placental TG accumulation. This might have contributed to the fetal overgrowth in GDM.

1 January 2008 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
NNNanda Nivedita
Nanda Nivedita
ZBZachariah Bobby
Zachariah Bobby
AHAbdoul Hamide
Abdoul Hamide
Hypothyroidism is the second most prevalent disorder in India and most cases require lifelong treatment. Disordered myocardial function is one of the complications of overt hypothyroidism. Dyslipidemia and lipid peroxidation are two biochemical derangements of hypothyroidism and both have been found to be associated. Still uncertainty remains regarding the origin of lipid peroxidation in this clinical condition. Besides, thyroid stimulating hormone or thyrotropin at a higher concentration can induce secretion of inflammatory cytokines and decrease the antioxidant status. Hence, we analyzed the association of lipid risk factors and thyrotropin in hypothyroidism with the extent of lipid peroxidation. A total of 42 primary hypothyroid patients volunteered to give fasting blood samples prior to therapy for the analysis of oxidative stress, thyroid and lipid profiles. Oxidative stress was confirmed by the increased levels of malondialdehyde and protein carbonylation and decreased levels of reduced glutathione. Simple correlation analyses revealed the association of lipid peroxidation with both thyrotropin and lipid risk factors. Partial correlation analyses showed that thyrotropin and lipid risk factors mutually influence their association with the higher malondialdehyde levels in these patients. Hyperthyrotropinemia may be considered not only as an index of the severity of hypothyroidism but also of the extent of the associated lipid peroxidation.